Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00014534 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: cisplatin
DRUG: doxorubicin hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]